On November 16, 2023, Wiggin and Dana was once again recognized by PitchBook as one of the most active law firms in its quarterly Global League Tables.  The firm was ranked in 10 categories for Venture Capital, Private Equity, and Mergers and Acquisitions in the U.S. and globally, including: Venture Capital Private Equity Mergers & […]

On November 15, 2023, Associate Jermaine Brookshire, Jr. will present on a panel at the Greater New Haven Chamber of Commerce’s business expo, “The Big Connect.” The Big Connect is a day-long conference offering attendees insightful professional development workshops, engagement with the shakers and movers in Connecticut’s business community, and networking opportunities entirely for free. Jermaine and […]

Wiggin and Dana recently represented Notable Labs, Inc. (Notable), a clinical stage therapeutics platform company developing predictive precision medicines for cancer patients, in its merger with VBL Therapeutics (Nasdaq: VBLT) and associated financing transaction. Through the merger, the combined company’s efforts will now be on the advancement of Notable’s proprietary Predictive Precision Medicines Platform (“PPMP”) and […]